| The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity J Barretina, G Caponigro, N Stransky, K Venkatesan, AA Margolin, S Kim, ... Nature 483 (7391), 603-307, 2012 | 7706 | 2012 |
| Genome-wide location and function of DNA binding proteins B Ren, F Robert, JJ Wyrick, O Aparicio, EG Jennings, I Simon, J Zeitlinger, ... Science Signalling 290 (5500), 2306, 2000 | 2722 | 2000 |
| Tankyrase inhibition stabilizes axin and antagonizes Wnt signalling SMA Huang, YM Mishina, S Liu, A Cheung, F Stegmeier, GA Michaud, ... Nature 461 (7264), 614-620, 2009 | 2171 | 2009 |
| Bidirectional transport of amino acids regulates mTOR and autophagy P Nicklin, P Bergman, B Zhang, E Triantafellow, H Wang, B Nyfeler, ... Cell 136 (3), 521-534, 2009 | 1943 | 2009 |
| COT drives resistance to RAF inhibition through MAP kinase pathway reactivation CM Johannessen, JS Boehm, SY Kim, SR Thomas, L Wardwell, ... Nature 468 (7326), 968-972, 2010 | 1712 | 2010 |
| Selective VPS34 inhibitor blocks autophagy and uncovers a role for NCOA4 in ferritin degradation and iron homeostasis in vivo WE Dowdle, B Nyfeler, J Nagel, RA Elling, S Liu, E Triantafellow, ... Nature cell biology 16 (11), 1069-1079, 2014 | 646 | 2014 |
| Development of a gene-editing approach to restore vision loss in Leber congenital amaurosis type 10 ML Maeder, M Stefanidakis, CJ Wilson, R Baral, LA Barrera, ... Nature medicine 25 (2), 229-233, 2019 | 613 | 2019 |
| Identification and characterization of NVP-BKM120, an orally available pan-class I PI3-kinase inhibitor SM Maira, S Pecchi, A Huang, M Burger, M Knapp, D Sterker, C Schnell, ... Molecular cancer therapeutics 11 (2), 317-328, 2012 | 595 | 2012 |
| Temporal regulation of RNA polymerase II by Srb10 and Kin28 cyclin-dependent kinases CJ Hengartner, VE Myer, SM Liao, CJ Wilson, SS Koh, RA Young Molecular cell 2 (1), 43-54, 1998 | 565 | 1998 |
| RNA polymerase II holoenzyme contains SWI/SNF regulators involved in chromatin remodeling. CJ Wilson, DM Chao, AN Imbalzano, GR Schnitzler, RE Kingston, ... Cell 84 (2), 235, 1996 | 522 | 1996 |
| Characterization of the novel and specific PI3Kα inhibitor NVP-BYL719 and development of the patient stratification strategy for clinical trials C Fritsch, A Huang, C Chatenay-Rivauday, C Schnell, A Reddy, M Liu, ... Molecular cancer therapeutics 13 (5), 1117-1129, 2014 | 470 | 2014 |
| FGFR genetic alterations predict for sensitivity to NVP-BGJ398, a selective pan-FGFR inhibitor V Guagnano, A Kauffmann, S Wöhrle, C Stamm, M Ito, L Barys, A Pornon, ... Cancer Discovery, 2012 | 352 | 2012 |
| Structure of the CAP-DNA complex at 2.5 Å resolution: a complete picture of the protein-DNA interface G Parkinson, C Wilson, A Gunasekera, YW Ebright, RE Ebright, ... Journal of molecular biology 260 (3), 395-408, 1996 | 331 | 1996 |
| Association of MTOR mutations with developmental brain disorders, including megalencephaly, focal cortical dysplasia, and pigmentary mosaicism GM Mirzaa, CD Campbell, N Solovieff, CP Goold, LA Jansen, S Menon, ... JAMA neurology 73 (7), 836-845, 2016 | 259 | 2016 |
| Class III phosphatidylinositol 4-kinase alpha and beta are novel host factor regulators of hepatitis C virus replication J Borawski, P Troke, X Puyang, V Gibaja, SC Zhao, C Mickanin, ... Journal of virology 83 (19), 10058-10074, 2009 | 210 | 2009 |
| PIKfyve, a class III PI kinase, is the target of the small molecular IL-12/IL-23 inhibitor apilimod and a player in Toll-like receptor signaling X Cai, Y Xu, AK Cheung, RC Tomlinson, A Alcázar-Román, L Murphy, ... Chemistry & biology 20 (7), 912-921, 2013 | 203 | 2013 |
| Lehá r, J., Kryukov, GV, Sonkin, D., et al.(2012) J Barretina, G Caponigro, N Stransky, K Venkatesan, AA Margolin, S Kim, ... The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer …, 0 | 188 | |
| Characterization of the mechanism of action of the pan class I PI3K inhibitor NVP-BKM120 across a broad range of concentrations SM Brachmann, J Kleylein-Sohn, S Gaulis, A Kauffmann, MJJ Blommers, ... Molecular cancer therapeutics 11 (8), 1747-1757, 2012 | 142 | 2012 |
| A strategy for rapid, high-confidence protein identification J Qin, D Fenyö, Y Zhao, W William, DM Chao, CJ Wilson, RA Young, ... Analytical chemistry 69 (19), 3995-4001, 1997 | 141 | 1997 |
| Pan-PIM kinase inhibition provides a novel therapy for treating hematologic cancers PD Garcia, JL Langowski, Y Wang, M Chen, J Castillo, C Fanton, M Ison, ... Clinical cancer research 20 (7), 1834-1845, 2014 | 133 | 2014 |
Richard YoungProfessor of Biology, MITVerifierad e-postadress på wi.mit.edu
